---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-125257"
form_type: "8-K"
ticker: "TLSI"
cik: "0001826667"
company_name: "TriSalus Life Sciences, Inc."
filed_at: "2022-12-08T23:59:59+00:00"
generated_at: "2026-06-21T07:41:40.537882+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# MedTech Acquisition adjourns special meeting to Dec 12 to seek votes for extension to June 2023

## Summary
- Special Meeting adjourned from Dec 7 to Dec 12, 2022 to solicit more votes for Extension Amendment.
- Extension Amendment would push business combination deadline from Dec 22, 2022 to June 22, 2023.
- Adjournment Proposal approved: 18,357,148 FOR, 4,839,932 AGAINST, 56,835 abstain.
- Company is pursuing merger with TriSalus Life Sciences as previously announced on Nov 11, 2022.
- Record date remains Oct 24, 2022; shareholders who already voted need not take action.

## SEC filing metadata
- accession: 0001104659-22-125257
- form_type: 8-K
- ticker: TLSI
- cik: 0001826667
- company_name: TriSalus Life Sciences, Inc.
- filed_at: 2022-12-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1826667/000110465922125257/0001104659-22-125257-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1826667/000110465922125257/tm2232243d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-125257
- JSON: https://secwatch.observer/filing/0001104659-22-125257.json
- Plain text: https://secwatch.observer/filing/0001104659-22-125257.txt

## Key facts
- Shareholder Votes
  TriSalus Life Sciences, Inc. shareholders approved The Adjournment Proposal at the 2022-12-07 meeting.
  - Outcome: passed
  - Meeting: 2022-12-07
  source text: The sole proposal that was presented at the Special Meeting was the “The Adjournment Proposal”, which is a proposal allowing the MedTech board of directors to adjourn the Special Meeting to a later date or dates, if necessary or appropriate, to provide more time to seek approval of the Extension Amendment. The MedTech stockholders approved the Adjournment Proposal. The voting results were as follows: FOR AGAINST ABSTAIN 18,357,148 4,839,932 56,835
  evidence_url: https://www.sec.gov/Archives/edgar/data/1826667/000110465922125257/0001104659-22-125257-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.